Alkermes (ALKS) Other Operating Expenses (2010 - 2026)
Alkermes (ALKS) reported Other Operating Expenses of -$35.9 million for Q1 2026, up 71.44% year-over-year from -$20.9 million in Q1 2025, and up 96.56% quarter-over-quarter from -$1.0 billion in Q4 2025.
Alkermes (ALKS) Other Operating Expenses (2010 - 2026) Analysis & Trends
Alkermes (ALKS) has 17 years of Other Operating Expenses data on file, last reported at -$35.9 million in Q1 2026.
- Other Operating Expenses for Q1 2026 came in at -$35.9 million, up 71.44% year-over-year; the trailing twelve-month figure through Mar 2026 was -$1.5 billion (down 30.25% YoY), and the FY2025 annual result was -$533.2 million, down 35.07% from the prior year.
- Other Operating Expenses grew to -$35.9 million in Q1 2026 per ALKS's latest filing, from -$1.0 billion in the prior quarter.
- Over five years, Other Operating Expenses peaked at $569.3 million in Q4 2023 and troughed at -$1.0 billion in Q4 2025.
- A 5-year average of -$109.5 million and a median of -$27.5 million in 2022 frame the typical range for Other Operating Expenses.
- The sharpest annual moves came in 2022 and 2023: Other Operating Expenses plunged 1591.94% in 2022, then surged 8192.76% in 2023.
- A 5-year view of Other Operating Expenses shows it stood at -$3.6 million in 2022, then surged by 16122.4% to $569.3 million in 2023, then tumbled by 222.74% to -$698.7 million in 2024, then sank by 49.3% to -$1.0 billion in 2025, then soared by 96.56% to -$35.9 million in 2026.
- Business Quant data shows ALKS's Other Operating Expenses at -$35.9 million in Q1 2026, -$1.0 billion in Q4 2025, and -$131.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -35.86 Mn |
| Dec 31, 2025 | -1.04 Bn |
| Sep 30, 2025 | -131.56 Mn |
| Jun 30, 2025 | -242.34 Mn |
| Mar 31, 2025 | -125.58 Mn |
| Dec 31, 2024 | -698.72 Mn |
| Sep 30, 2024 | -198.30 Mn |
| Jun 30, 2024 | -92.86 Mn |
| Mar 31, 2024 | 59.70 Mn |
| Dec 31, 2023 | 569.28 Mn |
| Sep 30, 2023 | 70.49 Mn |
| Jun 30, 2023 | 72.15 Mn |
| Mar 31, 2023 | 66.96 Mn |
| Sep 30, 2022 | -3.55 Mn |
| Jun 30, 2022 | 870,000.00 |
| Mar 31, 2022 | -19.07 Mn |
| Dec 31, 2021 | -750,000.00 |
| Sep 30, 2021 | -5.20 Mn |
| Jun 30, 2021 | 3.24 Mn |
| Mar 31, 2021 | 1.28 Mn |